Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Medicare

New Alzheimer’s drug is first to show it slows disease. But It’s facing a rocky rollout

Eisai Co.’s breakthrough Alzheimer’s drug — the first to show it slows the brain-destroying disease — is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties and complicated safety testing requirements.

Tribune News Service

Prisoners' advocate fights for Medicare rights for inmates

'It would actually save taxpayers' money to get Medicare in prisons.'

Newcastle Herald

Australian psychiatrists push for Medicare to subsidise ketamine for treatment-resistant depression

Application for subsidy follows results of a groundbreaking study into severe depression

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

The federal deficit nearly tripled, raising concern about the country's finances

The federal government's budget gap widened significantly in the first nine months of the fiscal year, as tax receipts slumped and spending increased.

WEKU

Sanders: Alzheimer's drug too expensive

"The high price of Leqembi threaten Medicare's finances, it will also negatively impact seniors on fixed incomes"

Salon

Medicare vs. Medicaid: What is the difference between these two health programs?

What to know to access the right one for your own, or a loved one’s needs.

Fortune

Medicare Telehealth Coverage Will Likely Be Extended By Congress: Kiplinger Economic Forecasts

COVID-era exceptions for telehealth coverage under Medicare are set to expire in 2024, but a bipartisan coalition in Congress appears likely to expand the benefit.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Ozempic isn't alone. A whole class of 'revolutionary' weight-loss drugs is on the market—but only for the wealthy

“We're experiencing something here that is very, very different, very exciting from a healthcare perspective, and very expensive,” says Aon's Michael Manolakis.

Fortune

Miracle new Alzheimer's drug which slows cognitive decline of disease to be rolled out

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

Daily Mirror

Ticket to Work Program: What Is It and How Does It Work?

This Social Security Administration program is underused and underpromoted, yet hundreds of thousands of American workers could access its benefits.

Kiplinger

Biden launches new push to limit health care costs, hoping to show he can save money for families

President Joe Biden plans to roll out a new set of initiatives Friday to reduce health care costs

The Independent UK

Bidenomics moves onto health care

The Biden administration is launching a crackdown on hidden fees in health care.

Axios

US government approves Alzheimer’s drug to slow cognitive decline

Some insurances, including the government-run Medicare, refused to pay for the drug until it received full approval.

Al Jazeera

Eisai Alzheimer's drug gets full US approval, widening access to the therapy

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators Thursday, a move expected to widen access to the first drug cleared based on its ability to slow progression of the mind-robbing disease.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Robodebt royal commission report handed down – as it happened

This blog is now closed.

The Independent UK

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease

WEKU

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

Roll Call

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

This Election Season, Beware of These False Promises

Many politicians offer a simplified view of the world—one in which government interventions are all benefits and no costs. That couldn't be further from the truth.

Roll Call

Expected Alzheimer’s drug approval signals new era in treatment - Roll Call

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

The Conversation

Why eating disorder treatments only work half the time, according to a psychologist

No single treatment will work for all people with eating disorders. Even the most highly researched evidence-based treatment may work for some people, but less so for others. When such treatments do not work, it can provoke anxiety.

Kiplinger

Leaving Retirement? Three Things to Consider Before You Unretire

Some of today’s retirees are finding they’re withdrawing too much from their retirement accounts and need to return to work to make ends meet.

Tribune News Service

Company's new wearable device will help diabetics eat right, lose weight

SAN DIEGO — San Diego's Dexcom, a maker of continuous glucose monitors, laid out plans for a new wearable device coming in 2024 for people with Type 2 diabetes who don't need insulin — a move that could help bring wearable health monitors closer to the mainstream.

Reason

Is Debating Debt Policy Actually Terrorism?

The fight over the debt ceiling has foreshadowed how the policy debates of the presidential election cycle are likely to go.

Fortune

Does Medicare cover cataract surgery? What you need to know

The answer, like so much about Medicare, isn’t simple.

1 … 104 105 106 107

People

Chiquita BrooksLaSure

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

207 stories

Biogen

198 stories

Social Security Administration

Western Sydney University

64 stories

the Alzheimer Association

37 stories

AAPI

30 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.